Clinical and genetic characteristics of Cornelia de Lange syndrome in pediatric patients
Pediatric Investigation · 2025-09 · 9 (3) · 293-299
DOI: 10.1002/ped4.70013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Investigation, online erschienen am 02.07.2025. Verfasst von Xiaoqiao Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Genetics, Metabolism Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beiji…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Importance Cornelia de Lange syndrome (CdLS) is a rare genetic disorder characterized by a spectrum of developmental and physical anomalies. Understanding the clinical and genetic landscape of CdLS in pediatric patients is crucial for improving diagnosis and management.
Objective
To investigate the clinical and genetic characteristics of 19 pediatric patients with CdLS in China, with a focus on identifying the association between genetic variants and clinical severity.
Methods
We performed whole exome sequencing on 19 patients with CdLS and compared their clinical characteristics based on the presence of null variants.
Results
Among the 19 patients, 16 (84.2%) showed global developmental delays and 14 (73.7%) experienced prenatal growth retardation and short stature. Craniofacial anomalies–short noses and anteverted nares were observed in 94.7% (18/19) of patients. Small hands and/or feet were present in 16 patients, skin manifestations (hirsutism or mottled skin) in six, and hearing loss in four. Genetic testing identified 19 variants in NIPBL (78.9%, 15/19), SMC1A (10.5%, 2/19), and RAD21 (10.5%, 2/19), including 13 novel variants. NIPBL null variants correlated significantly with more severe growth impairments ( P = 0.016) and microcephaly ( P = 0.004). Although complete protein function loss often correlated with more severe clinical presentations, no significant difference in clinical scoring was observed ( P = 0.600). Three patients treated with recombinant human growth hormone showed heterogeneous responses.
Interpretation
This study highlights the clinical heterogeneity of CdLS and suggests a potential link between specific genetic variants and disease severity. These findings warrant further research to optimize treatments and better understand the functional impact of these genetic variants.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, Genetics, Metabolism Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing China.
ORCID-Profile: Ming Cheng, Bingyan Cao, Lele Li, Chunxiu Gong
Zitieren
APA
Li, X., Cheng, M., Liu, M., Li, W., Li, Y., Cao, B., Wei, L., Ding, Y., Meng, X., Li, L., & Gong, C. (2025). Clinical and genetic characteristics of Cornelia de Lange syndrome in pediatric patients. Pediatric Investigation, 9(3), 293-299. https://doi.org/10.1002/ped4.70013
Vancouver
Li X, Cheng M, Liu M, Li W, Li Y, Cao B, et al. Clinical and genetic characteristics of Cornelia de Lange syndrome in pediatric patients. Pediatric Investigation. 2025;9(3):293-299. doi:10.1002/ped4.70013
BibTeX
@article{Li2025,
author = {Li, Xiaoqiao and Cheng, Ming and Liu, Min and Li, Wenjing and Li, Yuchuan and Cao, Bingyan and Wei, Liya and Ding, Yuan and Meng, Xi and Li, Lele and Gong, Chunxiu},
title = {Clinical and genetic characteristics of Cornelia de Lange syndrome in pediatric patients},
journal = {Pediatric Investigation},
year = {2025},
volume = {9},
number = {3},
pages = {293--299},
doi = {10.1002/ped4.70013}
}
EUVIMED